论文部分内容阅读
目的 :探讨超选择性脾动脉栓塞治疗肝硬化性门脉高压及脾功能亢进的临床价值。材料与方法 :采用超选择性脾动脉栓塞治疗肝硬化性门脉高压并脾功能亢进 11例 ,低压流控法部分性脾动脉栓塞治疗肝硬化性门脉高压并脾功能亢进 3例 ,观察治疗前后门脉压力 ,血液白细胞、血小板计数及肝功能的变化情况 ,判断其治疗效果。结果 :所有病人治疗后门脉压力明显降低 ,血液白细胞和血小板计数升高 ,肝功能GPT下降。 2例门脉高压、脾功能亢进复发 ,经第 2次栓塞治疗 ,取得显著疗效。无严重并发症发生。结论 :超选择性脾动脉栓塞是一种安全、有效的治疗肝硬化性门脉高压并脾功能亢进的方法 ,既可以降低门脉压力 ,又可以改善脾功能亢进。
Objective: To investigate the clinical value of superselective splenic arterial embolization in the treatment of liver cirrhosis portal hypertension and hypersplenism. Materials and Methods: Superselective splenic arterial embolization in the treatment of hepatic cirrhosis and hypersplenism in 11 cases, low pressure flow control of partial splenic arterial embolization in the treatment of cirrhosis and portal hypertension in 3 cases of hypersplenism, observation and treatment Before and after the portal pressure, white blood cells, platelet count and changes in liver function, to determine the treatment effect. Results: After treatment, the portal pressure of all patients was significantly lower, blood leucocyte and platelet count increased, and GPT decreased. 2 cases of portal hypertension, hypersplenism recurrence, the second embolization, and achieved significant results. No serious complications occurred. Conclusion: Superselective splenic arterial embolization is a safe and effective method for the treatment of cirrhotic portal hypertension and hypersplenism, which can not only reduce portal pressure but also improve hypersplenism.